Surgery Partners EBIT Margin 2013-2023 | SGRY
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Surgery Partners (SGRY) over the last 10 years. The current EBIT profit margin for Surgery Partners as of December 31, 2023 is .
| Surgery Partners EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2023-12-31 | $2.74B | $0.34B | 12.47% |
| 2023-09-30 | $2.72B | $0.34B | 12.34% |
| 2023-06-30 | $2.66B | $0.33B | 12.25% |
| 2023-03-31 | $2.61B | $0.31B | 11.69% |
| 2022-12-31 | $2.54B | $0.36B | 14.14% |
| 2022-09-30 | $2.44B | $0.38B | 15.48% |
| 2022-06-30 | $2.38B | $0.37B | 15.46% |
| 2022-03-31 | $2.31B | $0.35B | 15.25% |
| 2021-12-31 | $2.22B | $0.32B | 14.16% |
| 2021-09-30 | $2.16B | $0.30B | 13.69% |
| 2021-06-30 | $2.10B | $0.25B | 11.96% |
| 2021-03-31 | $1.93B | $0.24B | 12.17% |
| 2020-12-31 | $1.86B | $0.19B | 10.43% |
| 2020-09-30 | $1.83B | $0.17B | 9.29% |
| 2020-06-30 | $1.79B | $0.21B | 11.71% |
| 2020-03-31 | $1.86B | $0.22B | 11.86% |
| 2019-12-31 | $1.83B | $0.25B | 13.44% |
| 2019-09-30 | $1.81B | $0.12B | 6.76% |
| 2019-06-30 | $1.79B | $0.11B | 6.05% |
| 2019-03-31 | $1.78B | $0.10B | 5.40% |
| 2018-12-31 | $1.77B | $0.09B | 4.91% |
| 2018-09-30 | $1.74B | $0.22B | 12.59% |
| 2018-06-30 | $1.61B | $0.17B | 10.66% |
| 2018-03-31 | $1.47B | $0.17B | 11.26% |
| 2017-12-31 | $1.34B | $0.17B | 12.31% |
| 2017-09-30 | $1.19B | $0.15B | 12.82% |
| 2017-06-30 | $1.16B | $0.20B | 16.85% |
| 2017-03-31 | $1.17B | $0.21B | 17.94% |
| 2016-12-31 | $1.15B | $0.20B | 17.54% |
| 2016-09-30 | $1.10B | $0.15B | 13.87% |
| 2016-06-30 | $1.06B | $0.16B | 14.62% |
| 2016-03-31 | $1.00B | $0.15B | 14.46% |
| 2015-12-31 | $0.96B | $0.15B | 15.52% |
| 2015-06-30 | $0.53B | $0.10B | 18.95% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.120B | $2.743B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.869B | 15.67 |
| Cencora (COR) | United States | $48.051B | 19.18 |
| ICON (ICLR) | Ireland | $25.434B | 24.01 |
| DiDi Global (DIDIY) | China | $24.400B | 0.00 |
| Avantor (AVTR) | United States | $16.238B | 23.94 |
| Viatris (VTRS) | United States | $13.880B | 3.96 |
| CochLear (CHEOY) | $13.776B | 0.00 | |
| Revvity (RVTY) | United States | $12.539B | 21.83 |
| Medpace Holdings (MEDP) | United States | $12.267B | 40.36 |
| Charles River Laboratories (CRL) | United States | $11.798B | 21.50 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.548B | 0.00 |
| Natera (NTRA) | United States | $11.205B | 0.00 |
| Solventum (SOLV) | United States | $11.115B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.282B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.886B | 51.45 |
| Bausch + Lomb (BLCO) | Canada | $5.197B | 19.99 |
| Organon (OGN) | United States | $4.771B | 4.59 |
| Doximity (DOCS) | United States | $4.444B | 33.08 |
| PACS (PACS) | United States | $3.713B | 0.00 |
| Sotera Health (SHC) | United States | $3.227B | 15.83 |
| Progyny (PGNY) | United States | $3.079B | 51.68 |
| GoodRx Holdings (GDRX) | United States | $2.840B | 143.80 |
| Life Times (LTH) | United States | $2.783B | 30.76 |
| Premier (PINC) | United States | $2.511B | 9.19 |
| Teladoc Health (TDOC) | United States | $2.203B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.164B | 7.00 |
| Agilon Health (AGL) | United States | $2.055B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.811B | 0.00 |
| Agiliti (AGTI) | United States | $1.368B | 22.33 |
| NovoCure (NVCR) | Jersey | $1.360B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.331B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $0.985B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.760B | 7.86 |
| Embecta (EMBC) | United States | $0.594B | 3.92 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
| Enhabit (EHAB) | United States | $0.503B | 45.59 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.492B | 0.00 |
| LifeMD (LFMD) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.434B | 0.00 |
| Beauty Health (SKIN) | United States | $0.400B | 0.00 |
| CareDx (CDNA) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.376B | 60.17 |
| MultiPlan (MPLN) | United States | $0.371B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.349B | 0.00 |
| ModivCare (MODV) | United States | $0.335B | 4.44 |
| Sharecare (SHCR) | United States | $0.290B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.289B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| Biodesix (BDSX) | United States | $0.142B | 0.00 |
| So-Young (SY) | China | $0.125B | 41.83 |
| Oncology Institute (TOI) | United States | $0.085B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.078B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |